Literature DB >> 3918616

Falsely raised plasma digoxin concentrations in liver disease.

A A Nanji, D C Greenway.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918616      PMCID: PMC1417763          DOI: 10.1136/bmj.290.6466.432

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  Digitalis intoxication. A prospective clinical study with serum level correlations.

Authors:  G A Beller; T W Smith; W H Abelmann; E Haber; W B Hood
Journal:  N Engl J Med       Date:  1971-05-06       Impact factor: 91.245

2.  Endogenous digitalis-like substance in plasma of volume-expanded dogs.

Authors:  K A Gruber; J M Whitaker; V M Buckalew
Journal:  Nature       Date:  1980-10-23       Impact factor: 49.962

3.  An endogenous digoxin-like substance in patients with renal impairment.

Authors:  S W Graves; B Brown; R Valdes
Journal:  Ann Intern Med       Date:  1983-11       Impact factor: 25.391

4.  Increased circulating levels of an endogenous digoxin-like factor in hypertensive monkeys.

Authors:  K A Gruber; L L Rudel; B C Bullock
Journal:  Hypertension       Date:  1982 May-Jun       Impact factor: 10.190

5.  Digoxin-like immunoreactivity in premature and full-term infants not receiving digoxin therapy.

Authors:  M R Pudek; D W Seccombe; M F Whitfield; E Ling
Journal:  N Engl J Med       Date:  1983-04-14       Impact factor: 91.245

  5 in total
  7 in total

Review 1.  Endogenous factors with immunological and biological activity similar to cardiac glycosides: biochemical and pathophysiological implications.

Authors:  A Clerico; G Mariani
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

2.  Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.

Authors:  R G Morris; D B Frewin; N C Saccoia; W L Goldsworthy; W S Jeffries; A J McPhee
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Therapeutic drug monitoring.

Authors:  N Buchanan
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

4.  Renal disease and digoxin immunoassays.

Authors:  J McElnay; P M Hooymans
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-09

5.  Digitalis: where are we now?

Authors:  D A Chamberlain
Journal:  Br Heart J       Date:  1985-09

6.  Further evidence for the dissociation of digoxin-like immunoreactivity from Na+,K(+)-ATPase inhibitory activity.

Authors:  K Yamada; A Goto; M Ishii; M Yoshioka; T Sugimoto
Journal:  Experientia       Date:  1990-10-15

7.  The effect of renal and hepatic impairment and of spironolactone on digoxin immunoassays.

Authors:  R G Morris; D B Frewin; W B Taylor; M L Glistak; D R Lehmann
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.